Resveratrol Mitigates Inflammation by Modulating Tumor Necrosis Factor-Alpha Receptors (TNFRs) in a 2,4,6-Trinitrobenzene Sulfonic Acid (TNBS)-Induced Rat Model of Colitis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125779 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Médea Veszelka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Anatomy, and Neuroscience, Faculty of Science and Informatics, University of Szeged, 6726 Szeged, Hungary. Hauptthemen laut MEDLINE: Colitis, Resveratrol, Inflammation, Receptors, Tumor Necrosis Factor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Several substances with antioxidant and anti-inflammatory properties are currently being investigated as potential adjunctive or standalone treatments for inflammatory bowel disease (IBD). One such substance is resveratrol (RES), also known as 3,5,4′-trihydroxy-trans-stilbene, a natural dietary polyphenol with diverse health-promoting effects. In this study, male Wistar–Hannover rats received oral RES supplementation at doses of 5, 10, or 20 mg/kg/day for 28 days. On day 25 colitis was induced using intracolonic administration of 2,4,6-trinitrobenzene sulphonic acid (TNBS). Based on histological and planimetric analysis, the 10 mg/kg dose significantly reduced colonic ulceration and pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-α) expression compared to the TNBS group. Immunohistochemistry also revealed that RES at this dose attenuated the intensity of TNF-α receptors, namely TNFR1 and TNFR2. Furthermore, the concentration of lipocalin-2 (Lcn-2) was significantly elevated in TNBS-induced colitis. In conclusion, our findings suggest that RES may exert its protective effects partly through the modulation of TNF receptor signaling in TNBS-induced colitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Anatomy, and Neuroscience, Faculty of Science and Informatics, University of Szeged, 6726 Szeged, Hungary.
- HR-Pharma Ltd., 6726 Szeged, Hungary.
- Department of Microbiology, Faculty of Science and Informatics, University of Szeged, 6726 Szeged, Hungary.
ORCID-Profile: Bence Pál Barta, Mária Bagyánszki
Zitieren
APA
Veszelka, M., Hegyközi, J., Almási, N., Török, S., Barta, B. P., Nagy, I., Börzsei, D., Bódi, N., Bagyánszki, M., Szabó, R., & Varga, C. (2025). Resveratrol Mitigates Inflammation by Modulating Tumor Necrosis Factor-Alpha Receptors (TNFRs) in a 2,4,6-Trinitrobenzene Sulfonic Acid (TNBS)-Induced Rat Model of Colitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125779
Vancouver
Veszelka M, Hegyközi J, Almási N, Török S, Barta BP, Nagy I, et al. Resveratrol Mitigates Inflammation by Modulating Tumor Necrosis Factor-Alpha Receptors (TNFRs) in a 2,4,6-Trinitrobenzene Sulfonic Acid (TNBS)-Induced Rat Model of Colitis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125779
BibTeX
@article{Veszelka2025,
author = {Veszelka, Médea and Hegyközi, József and Almási, Nikoletta and Török, Szilvia and Barta, Bence Pál and Nagy, Izabella and Börzsei, Denise and Bódi, Nikolett and Bagyánszki, Mária and Szabó, Renáta and Varga, Csaba},
title = {Resveratrol Mitigates Inflammation by Modulating Tumor Necrosis Factor-Alpha Receptors (TNFRs) in a 2,4,6-Trinitrobenzene Sulfonic Acid (TNBS)-Induced Rat Model of Colitis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125779}
}
EUVIMED